Emergent BioSolutions (United States)
Emergent BioSolutions Inc. is an American multinational specialty biopharmaceutical company headquartered in Gaithersburg, Maryland. It develops vaccines and antibody therapeutics for infectious diseases and opioid overdoses, and it provides medical devices for biodefense purposes. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Emergent BioSolutions (United States), United States, covering academic research published from 2000 to 2025. Read More.
Open Access Percentage
59%
Total
Publications
819
Total Open
Publications
483
Total
Citations
26K
Open Access
Percentage
59%
Total
Publications
819
Total Open
Publications
483
Total
Citations
26K
Breakdown
Publisher Open
20%
Both
29%
Other Platform Open
10%
Closed
41%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 46%
182
Hybrid 24%
96
No Guarantees 30%
117
Other Platform Open
Domain 66%
211
Institution 50%
161
Other Internet 10%
32
Preprint 9%
28
Public 4%
12
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 216 |
doaj.org OAI-PMH Repository | Institution | 94 |
DOI | Other Internet | 21 |
Unknown Repository | Other Internet | 11 |
Preprints | Preprint | 8 |
Figshare | Public | 8 |
medRxiv | Preprint | 7 |
LA Referencia | Institution | 7 |
Europe PMC | Domain | 7 |
University of Oxford | Institution | 6 |